GALILEO: Rivaroxaban in TAVR patients.
Session The future is in the pipeline
Speaker Stephan Windecker
Congress : ESC Congress 2016
- Sub-topic : Miscellaneous
- Session type : Special Session
- FP Number : 5012
Members get moreJoin now
ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.